Cephamycin: Difference between revisions
No edit summary |
m Protected "Cephamycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
(No difference)
|
Revision as of 19:06, 27 September 2011
WikiDoc Resources for Cephamycin |
Articles |
---|
Most recent articles on Cephamycin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cephamycin at Clinical Trials.gov Clinical Trials on Cephamycin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cephamycin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cephamycin Discussion groups on Cephamycin Patient Handouts on Cephamycin Directions to Hospitals Treating Cephamycin Risk calculators and risk factors for Cephamycin
|
Healthcare Provider Resources |
Causes & Risk Factors for Cephamycin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics called cephems. Cephamycins were originally produced by Streptomyces, but synthetic ones have been produced as well.